Aura Biosciences is leveraging a novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology.
November 24, 2021
November 23, 2021
November 15, 2021
December 8, 2021 8:30 PM EST
Data Provided by Refinitiv. Minimum 15 minutes delayed.